Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Delamanid or pretomanid for treatment of multidrug resistant tuberculosis---spoilt for choice?

The Indian journal of tuberculosis - 1 Apr 2026

Sharma Amit, Chatterjee Poulomi, Shastry Shashank

Abstract excerpt

MDR TB treatment is now facing the perils of emerging resistance to BDQ(bedaquiline) and DLM(delaminid). Both DLM and PRT(pretomanid) belong to the nitroimidazole group of drugs. Drug resistance in Mycobacterium Tuberculosis (MTB) is an ever changing, continuous and evolving process whereby the bacteria finds new genetic mutations to escape destruction by the newer drugs. DLM and PRT belong to the same class of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antitubercular Agents
Share to Drug Resistance, Multiple, Bacterial

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mutation

Share to Mycobacterium tuberculosis

Share to Oxazoles

Share to Tuberculosis, Multidrug-Resistant

Source

Identifiers

PMID: 42031472
DOI: 10.1016/j.ijtb.2025.09.005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Delamanid or pretomanid for treatment of multidrug resistant tuberculosis---spoilt for choice?PMID 42031472Read ↗

Delamanid Resistance: Update and Clinical ManagementSemantic proximity Read ↗

Pretomanid resistance: An update on emergence, mechanisms and relevance for clinical practiceSemantic proximity Read ↗

Spontaneous Mutational Patterns and Novel Mutations for Delamanid Resistance in Mycobacterium tuberculosis.Semantic proximity Read ↗

Acquired Resistance to Bedaquiline and Delamanid in Therapy for Tuberculosis.Semantic proximity Read ↗

Delamanid and bedaquiline resistance patterns in Mycobacterium tuberculosis in Iran: A cross-sectional analysisSemantic proximity Read ↗

Systematic review of mutations associated with resistance to the new and repurposed Mycobacterium tuberculosis drugs bedaquiline, clofazimine, linezolid, delamanid and pretomanid.Semantic proximity Read ↗

Prevalence of Mycobacterium tuberculosis resistant to bedaquiline and delamanid in ChinaSemantic proximity Read ↗

Spontaneous mutations to delamanid and pretomanid resistance in Mycobacterium tuberculosis: SNPs confer high-level resistance.Semantic proximity Read ↗

Totally drug-resistant tuberculosis and adjunct therapies.Semantic proximity Read ↗

Widespread loss-of-function mutations implicating preexisting resistance to new or repurposed anti-tuberculosis drugsSemantic proximity Read ↗

Delamanid and Bedaquiline Resistance in Mycobacterium tuberculosis Ancestral Beijing Genotype Causing Extensively Drug-Resistant Tuberculosis in a Tibetan Refugee.Semantic proximity Read ↗

TB Anywhere, TB Everywhere. The First Case of pre-Extensively Drug Resistant Tuberculosis Treated with BPaL in Italy: Challenges and Opportunities for Transborder Collaboration.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.